Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203

UnknownOBSERVATIONAL
Enrollment

165

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Ischemic Heart Failure
Trial Locations (14)

10032

Columbia University Medical Center, New York

19104

University of Pennsylvania Health System, Philadelphia

21287

Johns Hopkins University, Baltimore

33613

Pepin Heart Institute, Tampa

35211

Cardiology, P.C., Birmingham

40536

University of Kentucky Gill Heart Institute, Lexington

44309

Summa Health System, Akron

45219

The Carl and Edyth Lindner Center for Research & Education at The Christ Hospital, Cincinnati

48601

Michigan Cardiovascular Institute, Saginaw

50026

Iowa Heart Center, Des Moines

63110

Washington University in St. Louis, St Louis

64111

Saint Luke's Hospital of Kansas City, Kansas City

84132

University of Utah, Salt Lake City

32610-0277

University of Florida, Gainsville

Sponsors
All Listed Sponsors
lead

Juventas Therapeutics, Inc.

INDUSTRY